Is Mounjaro vegan? What the ingredients actually tell you

You're checking the label before committing, here's what it says

Plenty of people planning to start a new medicine look at the inactive ingredients the way they'd scan a food packet. It's a reasonable habit. Mounjaro's Summary of Product Characteristics, published on the Electronic Medicines Compendium, lists the full excipient profile for the KwikPen solution. The active substance (tirzepatide) is a synthetic dual GIP and GLP-1 receptor agonist produced through recombinant DNA technology in a laboratory setting, and if you have ever wondered whether tirzepatide is it Mounjaro or something distinct, our page clarifying the relationship between tirzepatide and Mounjaro explains exactly how the two names relate. It is not extracted from animal glands, organs or tissue, which is the starting reassurance many people need. You can review the full ingredient list in the Mounjaro SmPC on the eMC rather than relying on a summary.

The excipients are where things get more nuanced. The formulation contains polysorbate 80, a surfactant that keeps the solution stable. Polysorbate 80 is synthesised from sorbitol and fatty acids; the fatty acids can originate from plant oils or from animal tallow, and the manufacturing source is not always disclosed in the SmPC. It also contains L-arginine hydrochloride (an amino acid that in pharmaceutical grade is typically synthetic), citric acid monohydrate, sodium citrate, glycerol, and water for injections. Of these, glycerol is the one most commonly flagged by vegan patients: pharmaceutical glycerol may be animal-derived, plant-derived, or synthetic. The SmPC does not specify the origin. If that level of certainty matters to you, raising it directly with Eli Lilly UK before starting is the right move.

You can read more about what Mounjaro is and how it works on our Mounjaro overview page, which covers the clinical picture alongside the practicalities.

Does the pen itself raise any concerns?

Beyond the solution, the KwikPen is a device. Injectable pens contain rubber-stoppers (plungers) that contact the medicine. Rubber components in pharmaceutical devices often include stearic acid as a processing aid during manufacture, and stearic acid is frequently tallow-derived. This is not unique to Mounjaro; it is a near-universal feature of injectable medicines packaged in glass cartridges with rubber closures, including vaccines and insulin. The Vegan Society and similar bodies generally acknowledge that medicines in this category sit in a different ethical space from food, the Medicines Act does not require vegan certification, and for most people who follow a plant-based diet, the clinical benefit of a prescribed medicine takes precedence. That is ultimately a personal decision, and one worth having openly with your prescribing team.

The NHS patient information for tirzepatide does not flag animal-derived excipients as a specific contraindication for vegans, reflecting the broader medicines-regulation position. You can check the NHS medicines page for tirzepatide at nhs.uk/medicines/tirzepatide/ for the patient-facing summary of ingredients and what to tell your prescriber before starting.

If you want to understand how the medicine actually works at a receptor level, our page on tirzepatide goes into the mechanism in plain language.

What does this mean in practice if you're vegan?

For most people following a vegan diet, the practical question is whether these trace excipients are a dealbreaker. There is no universally correct answer. Organisations that advise vegans on medicines (including the Vegan Society's medicines position) tend to recommend speaking with a GP or pharmacist rather than refusing treatment, particularly for a medicine prescribed for a recognised health condition. The Medicines and Healthcare products Regulatory Agency regulates Mounjaro for safety and efficacy, not for dietary certification, and the excipient amounts involved are pharmacologically inactive and present in very small quantities per dose.

If you are also thinking about how Mounjaro interacts with a predominantly plant-based diet in terms of nutrition (specifically protein intake, which matters on a reduced-appetite regimen) that is a separate and equally valid question for your prescriber, and questions around lifestyle factors such as alcohol come up just as often, so our Mounjaro and alcohol forum page brings together the conversations people are already having on that topic. People eating vegan diets sometimes need to think more carefully about protein sources when appetite falls significantly. It is the kind of detail that comes up in a proper clinical review rather than at the checkout stage.

For broader context on how weight-loss treatment is assessed and chosen, our weight-loss treatment overview explains the landscape without pushing a particular path. And if you are weighing up whether Mounjaro is the right option given your full picture, the evidence on Mounjaro's effectiveness sets out what the clinical trials actually showed.

Before you start: a prescriber reviews the details with you

Mounjaro is a prescription-only medicine. A clinical assessment comes before any dispensing, and that assessment is the right moment to raise the vegan question formally, so it is documented and your prescriber can advise based on your complete medical history. At nume, a GPhC-registered Independent Prescriber reads every consultation personally. There are no algorithms making that call. If you order by noon on a weekday, your consultation is reviewed the same day; if approved as clinically suitable, your treatment is dispatched that afternoon and delivered free the next working day by DPD, in plain packaging.

Our clinical team's approach is described on the clinical team page if you want to know who is reviewing your case. The FAQs also cover common pre-treatment questions. You can find current treatment pricing and options, including what is included in one transparent cost, on the weight-loss treatments page.